Screened 2026-09-08 · the tape above runs as of 23:00 UTC · 16 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markup label.
ServiceNow holds its Markup at $134.21. The statistical read favours the sellers, held for 22 days.
As held on the ledger · 2026-09-08
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 22 days
Price at the screen
$134.21
Valuation
83.88 trailing · 26.81 forward price to earnings
Values screen
PASS· score 76.4
Beta
0.97
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
9.23%
Below 33%
Interest-bearing debt is just 9.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
14.48%
Below 33%
Cash held in interest-bearing accounts and securities is 14.5% of assets, under the one-third limit.
Pass
Receivables
24.40%
Below 49%
Money owed to the company is 24.4% of assets, under the 49% limit.
Pass
Revenue purity
3.40%
Below 5%
Only 3.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads FAIR VALUE: it trades at roughly a 1% discount to our $135.07 fair value, moderate competitive moat, 24.00% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. A 0.6% margin of safety to the base estimate.
Third-party analyst targets: 46 covering, consensus Strong Buy. The average target sits +4% from the screen price.
Reading the gap · Our model and the Street both land near today's price: fairly valued, with no strong edge either way.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Cloud Workflows Beacon in a Crowded Sky
Imagine a world where digitalization is powered by a cloud-based system that streamlines every aspect of workflow management, that's ServiceNow. It stands out as a provider of digital workflows in a landscape where efficiency is paramount, with a revenue growth of 24%, bolstering its position as a key player in tech application software. The market has a strong buy consensus with a median target of $140, a nod to its robust financials and forward P/E of 25.9x.
At $129.75, ServiceNow is trading just below our fair value of $135.07, offering a slim 4% margin of safety. With a profit margin of 11% and a respectable ROE of 14%, the company exhibits solid financial health. Its moderate moat indicates it has a competitive edge, though not impenetrable in the rapidly evolving tech landscape. The ethical screen gives ServiceNow a pass, aligning with our investment ethos.
While ServiceNow's numbers look compelling, the risk lies in its lofty valuation and the crowded tech space where new entrants and innovative solutions can quickly disrupt the status quo. As with any investment in cyclical sectors, the forward-looking P/E might be masking future volatility, especially if the growth rate slows. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
NOW trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-23Markup$129.75+25.7%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 25.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (44 analysts) rates it strong buy, with a mean price target of $143.
2026-07-22Markup$103.24+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (44 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-21Markup$103.24+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (44 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-20Markup$103.24+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (44 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-19Markup$103.24-8.2%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 8.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (44 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18Markup$112.45+0.0%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (44 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-17Markup$112.45+0.0%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (44 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-16Markup$112.45+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (44 analysts) rates it strong buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-03Markup$112.45+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$112.45Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
